Core Non Currrent Assets Other vs Accounts Payable Analysis

CLB Stock

USD 17.90 0.26 1.43%

Core Laboratories financial indicator trend analysis is way more than just evaluating Core Laboratories prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Core Laboratories is a good investment. Please check the relationship between Core Laboratories Non Currrent Assets Other and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Non Currrent Assets Other vs Accounts Payable

Non Currrent Assets Other vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Core Laboratories Non Currrent Assets Other account and Accounts Payable. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Core Laboratories' Non Currrent Assets Other and Accounts Payable is 0.19. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Core Laboratories NV, assuming nothing else is changed. The correlation between historical values of Core Laboratories' Non Currrent Assets Other and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Core Laboratories NV are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Non Currrent Assets Other i.e., Core Laboratories' Non Currrent Assets Other and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.19

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Accounts Payable

An accounting item on the balance sheet that represents Core Laboratories obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Core Laboratories are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most indicators from Core Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Core Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

The current year's Tax Provision is expected to grow to about 10.8 M, whereas Selling General Administrative is forecasted to decline to about 34.6 M.

	2021	2022	2023	2024 (projected)
Gross Profit	83.8M	78.9M	94.0M	171.1M
Total Revenue	470.3M	489.7M	509.8M	619.3M

Gross Profit Total Revenue

Core Laboratories fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock Total Equity	Common Stock
Total Assets		0.81	0.64	0.86	0.41	0.82	0.8	0.52	0.7	0.54	0.93	-0.21	0.54	0.73	0.54	0.85	0.68	0.75	-0.29	0.9	0.8	0.82	0.34	0.44	0.84	0.57
Short Long Term Debt Total	0.81		0.64	0.64	-0.16	0.77	1.0	0.36	0.34	0.43	0.81	-0.32	0.43	0.52	0.2	0.99	0.39	0.64	-0.43	0.97	0.72	0.57	0.41	0.5	0.53	0.51
Other Current Liab	0.64	0.64		0.83	-0.1	0.37	0.61	0.81	0.61	0.74	0.45	0.09	0.74	0.82	0.24	0.68	0.2	0.54	-0.8	0.75	0.33	0.76	0.25	0.16	0.51	0.53
Total Current Liabilities	0.86	0.64	0.83		0.31	0.52	0.6	0.81	0.91	0.82	0.63	0.06	0.82	0.93	0.57	0.68	0.56	0.77	-0.6	0.79	0.47	0.96	0.05	0.21	0.8	0.66
Total Stockholder Equity	0.41	-0.16	-0.1	0.31		0.31	-0.17	0.13	0.52	0.09	0.36	0.01	0.09	0.28	0.67	-0.11	0.66	0.18	0.33	-0.02	0.36	0.37	-0.1	0.03	0.57	0.1
Property Plant And Equipment Net	0.82	0.77	0.37	0.52	0.31		0.77	0.08	0.3	0.26	0.91	-0.57	0.26	0.32	0.5	0.77	0.65	0.49	0.04	0.76	0.99	0.45	0.45	0.32	0.69	0.43
Net Debt	0.8	1.0	0.61	0.6	-0.17	0.77		0.31	0.3	0.38	0.82	-0.36	0.38	0.48	0.19	0.99	0.37	0.62	-0.4	0.96	0.73	0.53	0.42	0.54	0.5	0.51
Retained Earnings	0.52	0.36	0.81	0.81	0.13	0.08	0.31		0.77	0.75	0.21	0.39	0.75	0.94	0.28	0.38	0.23	0.55	-0.84	0.5	0.05	0.86	-0.16	0.17	0.43	0.4
Accounts Payable	0.7	0.34	0.61	0.91	0.52	0.3	0.3	0.77		0.76	0.44	0.19	0.76	0.89	0.66	0.39	0.6	0.69	-0.47	0.52	0.27	0.92	-0.13	0.07	0.75	0.58
Cash	0.54	0.43	0.74	0.82	0.09	0.26	0.38	0.75	0.76		0.26	0.25	1.0	0.81	0.56	0.44	0.44	0.48	-0.67	0.55	0.24	0.82	-0.11	-0.11	0.67	0.56
Non Current Assets Total	0.93	0.81	0.45	0.63	0.36	0.91	0.82	0.21	0.44	0.26		-0.43	0.26	0.45	0.42	0.85	0.59	0.62	-0.04	0.85	0.88	0.55	0.5	0.53	0.71	0.51
Non Currrent Assets Other	-0.21	-0.32	0.09	0.06	0.01	-0.57	-0.36	0.39	0.19	0.25	-0.43		0.25	0.3	-0.16	-0.33	-0.01	-0.24	-0.23	-0.27	-0.49	0.21	-0.25	-0.33	0.04	-0.48
Cash And Short Term Investments	0.54	0.43	0.74	0.82	0.09	0.26	0.38	0.75	0.76	1.0	0.26	0.25		0.81	0.56	0.44	0.44	0.48	-0.67	0.55	0.24	0.82	-0.11	-0.11	0.67	0.56
Net Receivables	0.73	0.52	0.82	0.93	0.28	0.32	0.48	0.94	0.89	0.81	0.45	0.3	0.81		0.47	0.55	0.48	0.67	-0.72	0.66	0.3	0.97	-0.04	0.2	0.67	0.48
Common Stock Shares Outstanding	0.54	0.2	0.24	0.57	0.67	0.5	0.19	0.28	0.66	0.56	0.42	-0.16	0.56	0.47		0.23	0.78	0.39	-0.1	0.31	0.54	0.57	-0.26	-0.07	0.77	0.55
Non Current Liabilities Total	0.85	0.99	0.68	0.68	-0.11	0.77	0.99	0.38	0.39	0.44	0.85	-0.33	0.44	0.55	0.23		0.38	0.68	-0.44	0.99	0.72	0.6	0.46	0.53	0.56	0.57
Inventory	0.68	0.39	0.2	0.56	0.66	0.65	0.37	0.23	0.6	0.44	0.59	-0.01	0.44	0.48	0.78	0.38		0.35	0.07	0.44	0.72	0.64	0.02	-0.03	0.86	0.18
Other Current Assets	0.75	0.64	0.54	0.77	0.18	0.49	0.62	0.55	0.69	0.48	0.62	-0.24	0.48	0.67	0.39	0.68	0.35		-0.43	0.74	0.41	0.73	0.04	0.31	0.54	0.68
Other Stockholder Equity	-0.29	-0.43	-0.8	-0.6	0.33	0.04	-0.4	-0.84	-0.47	-0.67	-0.04	-0.23	-0.67	-0.72	-0.1	-0.44	0.07	-0.43		-0.5	0.09	-0.6	0.17	-0.24	-0.12	-0.48
Total Liab	0.9	0.97	0.75	0.79	-0.02	0.76	0.96	0.5	0.52	0.55	0.85	-0.27	0.55	0.66	0.31	0.99	0.44	0.74	-0.5		0.71	0.71	0.4	0.49	0.64	0.62
Property Plant And Equipment Gross	0.8	0.72	0.33	0.47	0.36	0.99	0.73	0.05	0.27	0.24	0.88	-0.49	0.24	0.3	0.54	0.72	0.72	0.41	0.09	0.71		0.44	0.43	0.26	0.72	0.33
Total Current Assets	0.82	0.57	0.76	0.96	0.37	0.45	0.53	0.86	0.92	0.82	0.55	0.21	0.82	0.97	0.57	0.6	0.64	0.73	-0.6	0.71	0.44		-0.02	0.15	0.79	0.5
Short Term Debt	0.34	0.41	0.25	0.05	-0.1	0.45	0.42	-0.16	-0.13	-0.11	0.5	-0.25	-0.11	-0.04	-0.26	0.46	0.02	0.04	0.17	0.4	0.43	-0.02		0.14	0.17	0.0
Intangible Assets	0.44	0.5	0.16	0.21	0.03	0.32	0.54	0.17	0.07	-0.11	0.53	-0.33	-0.11	0.2	-0.07	0.53	-0.03	0.31	-0.24	0.49	0.26	0.15	0.14		-0.04	0.37
Common Stock Total Equity	0.84	0.53	0.51	0.8	0.57	0.69	0.5	0.43	0.75	0.67	0.71	0.04	0.67	0.67	0.77	0.56	0.86	0.54	-0.12	0.64	0.72	0.79	0.17	-0.04		0.42
Common Stock	0.57	0.51	0.53	0.66	0.1	0.43	0.51	0.4	0.58	0.56	0.51	-0.48	0.56	0.48	0.55	0.57	0.18	0.68	-0.48	0.62	0.33	0.5	0.0	0.37	0.42

Click cells to compare fundamentals

Core Laboratories Account Relationship Matchups

Core Laboratories fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	774.7M	568.6M	580.9M	578.4M	586.4M	550.2M
Short Long Term Debt Total	381.8M	327.0M	250.3M	222.4M	215.4M	217.2M
Other Current Liab	50.8M	49.8M	40.9M	39.6M	39.7M	47.9M
Total Current Liabilities	111.6M	89.8M	90.8M	103.1M	88.1M	100.6M
Total Stockholder Equity	182.1M	75.6M	161.0M	189.0M	224.8M	131.8M
Property Plant And Equipment Net	199.2M	181.7M	172.3M	157.4M	153.5M	120.1M
Net Debt	370.7M	313.2M	232.6M	207.0M	200.3M	187.0M
Retained Earnings	160.5M	50.5M	68.3M	85.9M	120.8M	194.2M
Accounts Payable	35.6M	23.0M	29.7M	45.8M	33.5M	35.9M
Cash	11.1M	13.8M	17.7M	15.4M	15.1M	14.4M
Non Current Assets Total	553.4M	402.7M	391.8M	366.7M	363.3M	325.2M
Non Currrent Assets Other	(71.3M)	(76.9M)	(74.6M)	(73.0M)	29.4M	30.8M
Cash And Short Term Investments	11.1M	13.8M	17.7M	15.4M	15.1M	14.4M
Net Receivables	131.6M	83.2M	96.8M	106.9M	123.1M	129.1M
Common Stock Shares Outstanding	44.6M	45.0M	46.7M	46.8M	47.5M	40.8M
Liabilities And Stockholders Equity	774.7M	568.6M	580.9M	578.4M	586.4M	550.2M
Non Current Liabilities Total	480.9M	403.3M	329.1M	286.3M	268.5M	267.2M
Inventory	50.2M	38.2M	45.4M	60.4M	71.7M	39.7M
Other Current Assets	28.4M	30.7M	29.1M	28.9M	13.2M	26.0M
Other Stockholder Equity	26.8M	31.2M	101.6M	105.6M	108.6M	114.0M
Total Liab	592.5M	493.0M	419.9M	389.4M	356.6M	367.8M
Property Plant And Equipment Gross	199.2M	181.7M	172.3M	157.4M	181.0M	118.3M
Total Current Assets	221.2M	165.8M	189.1M	211.7M	223.1M	225.0M
Accumulated Other Comprehensive Income	(6.3M)	(7.2M)	(10.1M)	(3.8M)	(5.0M)	(5.2M)
Short Term Debt	11.8M	11.4M	12.3M	11.7M	10.2M	14.1M
Intangible Assets	17.5M	8.6M	8.1M	7.5M	6.9M	6.6M
Other Liab	109.9M	87.7M	91.1M	75.6M	86.9M	66.4M
Other Assets	119.4M	179.4M	107.7M	102.3M	1.0	0.95
Long Term Debt	305.3M	259.4M	188.6M	172.4M	198.2M	229.8M
Property Plant Equipment	123.5M	115.3M	172.3M	157.4M	181.0M	126.1M
Current Deferred Revenue	13.4M	5.5M	7.8M	5.9M	4.8M	4.5M
Treasury Stock	(29.4M)	(14.1M)	(4.1M)	(1.4M)	(1.6M)	(1.6M)
Net Tangible Assets	11.7M	19.6M	(58.5M)	115.6M	104.1M	109.3M
Noncontrolling Interest In Consolidated Entity	4.3M	4.1M	4.6M	4.7M	5.4M	4.6M
Retained Earnings Total Equity	160.5M	50.5M	68.3M	85.9M	77.4M	73.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
CRM	Salesforce
MSFT	Microsoft

When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:

How To Invest In Core

Details

Is Core Stock a good investment?

Details

What is Core Laboratories' Net Worth?

Details

Largest Oil & Gas Equipment & Services Companies

View

Largest Energy Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Core Stock analysis

When running Core Laboratories' price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.

	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	CEOs Directory Screen CEOs from public companies around the world
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios

Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.374

Dividend Share

0.04

Earnings Share

0.51

Revenue Per Share

10.935

Quarterly Revenue Growth

0.01

The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Core Non Currrent Assets Other vs Accounts Payable Analysis

Non Currrent Assets Other vs Accounts Payable

Non Currrent Assets Other vs Accounts Payable Correlation Analysis

Correlation Coefficient

Non Currrent Assets Other

Accounts Payable

Core Laboratories fundamental ratios Correlations

Core Laboratories Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Core Laboratories fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Core Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net
Non Current Liabilities Total	+ 0.99	Net Debt
Total Liab	+ 0.99	Non Current Liabilities Total

Other Stockholder Equity	- 0.84	Retained Earnings
Other Stockholder Equity	- 0.8	Other Current Liab
Other Stockholder Equity	- 0.72	Net Receivables
Other Stockholder Equity	- 0.67	Cash And Short Term Investments
Other Stockholder Equity	- 0.67	Cash
Total Current Assets	- 0.6	Other Stockholder Equity